The ferritin level at which iron therapy is indicated differs between pregnancy and non-pregnancy. The Swiss expert letter from the SGGG sets this level at 30 µg/l during pregnancy, regardless of the hemoglobin level [1]. The Swiss general practice guideline states that, outside of pregnancy, in cases of iron deficiency without anemia, treatment is only considered an indication on a case-by-case basis when levels fall below 15 ng/ml [3]. The following article compares these two situations side by side.
Autoren
- Jens Dehn
Publikation
- GYNÄKOLOGIE PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Pulmonology – Lobus venae acygos
- Atopic Dermatitis: Precisely Targeting Immunological Targets
Interleukin blockade or OX40-(L) inhibition?
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Across All Types of Cancer
Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
- Obesity: More than half of those affected have fatty liver disease
From screening to multimodal intervention with GLP-1-RA or resmetirom
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Preclinical Study on a Special Ginkgo biloba Extract
What role do proanthocyanidins play?
- Myasthenia gravis: immunomodulatory therapies for long-term treatment